BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Noh J, Kim HC, Shin A, Yeom H, Jang SY, Lee JH, Kim C, Suh I. Prevalence of Comorbidity among People with Hypertension: The Korea National Health and Nutrition Examination Survey 2007-2013. Korean Circ J. 2016;46:672-680. [PMID: 27721859 DOI: 10.4070/kcj.2016.46.5.672] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Wong ELY, Xu RH, Cheung AWL. Health-related quality of life among patients with hypertension: population-based survey using EQ-5D-5L in Hong Kong SAR, China. BMJ Open 2019;9:e032544. [PMID: 31562165 DOI: 10.1136/bmjopen-2019-032544] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
2 Guerrero-Díaz DV, Hernández-Vásquez A, Montoya-Rivera WC, Rojas-Roque C, Chacón Díaz MA, Bendezu-Quispe G. Undiagnosed hypertension in Peru: analysis of associated factors and socioeconomic inequalities, 2019. Heliyon 2021;7:e07516. [PMID: 34296015 DOI: 10.1016/j.heliyon.2021.e07516] [Reference Citation Analysis]
3 Marques da Silva P, Lima MJ, Neves PM, Espiga de Macedo M. Prevalence of cardiovascular risk factors and other comorbidities in patients with hypertension in Portuguese primary health care populations: The PRECISE study. Rev Port Cardiol (Engl Ed) 2019;38:427-37. [PMID: 31307727 DOI: 10.1016/j.repc.2018.09.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Ungvari Z, Toth P, Tarantini S, Prodan CI, Sorond F, Merkely B, Csiszar A. Hypertension-induced cognitive impairment: from pathophysiology to public health. Nat Rev Nephrol 2021. [PMID: 34127835 DOI: 10.1038/s41581-021-00430-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Vasyuk YA, Dovzhenko TV, Dubrovskaya TI, Nesterova EA, Shupenina EY. [Characteristics of arterial hypertension clinical course in patients with obesity and anxiety-depressive disorders]. Ter Arkh 2021;93:94-9. [PMID: 33720633 DOI: 10.26442/00403660.2021.01.200567] [Reference Citation Analysis]
6 Qu Z, Parry M, Liu F, Wen X, Li J, Zhang Y, Wang D, Li X. Self-management and blood pressure control in China: a community-based multicentre cross-sectional study. BMJ Open 2019;9:e025819. [PMID: 30898823 DOI: 10.1136/bmjopen-2018-025819] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Garcia-Carretero R, Barquero-Perez O, Mora-Jimenez I, Soguero-Ruiz C, Goya-Esteban R, Ramos-Lopez J. Identification of clinically relevant features in hypertensive patients using penalized regression: a case study of cardiovascular events. Med Biol Eng Comput 2019;57:2011-26. [PMID: 31346948 DOI: 10.1007/s11517-019-02007-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Lai AY, McLaurin J. Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease. J Neurochem 2018;144:659-68. [PMID: 28722749 DOI: 10.1111/jnc.14130] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
9 De Sanctis V. Prevalence, Clinical Manifestations, and Biochemical Data of Hypertensive versus Normotensive Symptomatic Patients with COVID-19: A Comparative Study. Acta Biomed 2020;91:e2020164. [PMID: 33525211 DOI: 10.23750/abm.v91i4.10540] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Peeters LEJ, Kester MP, Feyz L, Van Den Bemt PMLA, Koch BCP, Van Gelder T, Versmissen J. Pharmacokinetic and pharmacodynamic considerations in the treatment of the elderly patient with hypertension. Expert Opin Drug Metab Toxicol 2019;15:287-97. [PMID: 30880496 DOI: 10.1080/17425255.2019.1588249] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
11 Lee H, Kim S, Choi K, Yoo B, Cha D, Jung HO, Ryu D, Choi JH, Lee KJ, Park TH, Oh JH, Kim SM, Choi J, Kim KH, Shim J, Kim W, Choi S, Park D, Song P, Hong T, Rhee M, Rha S, Park SW. A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and the Tolerability of a Triple Combination of Amlodipine/Losartan/Rosuvastatin in Patients With Comorbid Essential Hypertension and Hyperlipidemia. Clinical Therapeutics 2017;39:2366-79. [DOI: 10.1016/j.clinthera.2017.10.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
12 Oh GC, Kang KS, Park CS, Sung HK, Ha KH, Kim HC, Park S, Ihm SH, Lee HY. Metabolic syndrome, not menopause, is a risk factor for hypertension in peri-menopausal women. Clin Hypertens 2018;24:14. [PMID: 30349737 DOI: 10.1186/s40885-018-0099-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
13 Moon SW, Kim SY, Chung MP, Yoo H, Jeong SH, Kim DS, Song JW, Lee HL, Choi SM, Kim YW, Kim YH, Park CS, Park SW, Park JS, Jegal Y, Lee J, Uh ST, Kim TH, Lee JH, Kim YH, Shin B, Lee HK, Yang SH, Lee H, Kim SH, Lee EJ, Choi HS, Shin H, Park YB, Shin JW, Park MS. Longitudinal Changes in Clinical Features, Management, and Outcomes of Idiopathic Pulmonary Fibrosis. A Nationwide Cohort Study. Ann Am Thorac Soc 2021;18:780-7. [PMID: 33270528 DOI: 10.1513/AnnalsATS.202005-451OC] [Reference Citation Analysis]
14 Lee MJ, Romero S, Jia H, Velozo CA, Gruber-baldini AL, Shulman LM. Self-efficacy for managing hypertension and comorbid conditions. WJH 2019;9:30-41. [DOI: 10.5494/wjh.v9.i3.30] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Dong G, Feng J, Sun F, Chen J, Zhao XM. A global overview of genetically interpretable multimorbidities among common diseases in the UK Biobank. Genome Med 2021;13:110. [PMID: 34225788 DOI: 10.1186/s13073-021-00927-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wang Y, Tan NC, Jafar TH. Ethnic variation, socioeconomic status, and factors associated with cardio-metabolic multi-morbidity among uncontrolled hypertension in multiethnic Singapore. J Hum Hypertens 2021. [PMID: 33837292 DOI: 10.1038/s41371-020-00457-5] [Reference Citation Analysis]